Biora Therapeutics (BIOR) to Release Earnings on Thursday

Biora Therapeutics (NASDAQ:BIOR) will issue its quarterly earnings data after the market closes on Thursday, November 14th. Analysts expect the company to announce earnings of ($3.85) per share for the quarter. Parties that are interested in registering for the company’s conference call can do so using this link.

Biora Therapeutics (NASDAQ:BIOR) last posted its earnings results on Monday, August 12th. The company reported ($3.50) EPS for the quarter, beating analysts’ consensus estimates of ($4.50) by $1.00. The company had revenue of $0.32 million during the quarter. On average, analysts expect Biora Therapeutics to post $-12 EPS for the current fiscal year and $-12 EPS for the next fiscal year.

Biora Therapeutics Stock Performance

Shares of Biora Therapeutics stock opened at $2.72 on Tuesday. Biora Therapeutics has a 1 year low of $2.38 and a 1 year high of $19.90. The company has a market capitalization of $10.00 million, a P/E ratio of -0.05 and a beta of 1.27. The company’s fifty day moving average is $5.07 and its two-hundred day moving average is $6.14.

Analysts Set New Price Targets

Separately, HC Wainwright reissued a “buy” rating and set a $150.00 price objective on shares of Biora Therapeutics in a research report on Tuesday, August 13th.

Biora Therapeutics Company Profile

Biora Therapeutics, Inc, a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases.